Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
:max_bytes(150000):strip_icc()/INV_MerckCampus_GettyImages-1230787969-a6f0ec5d61894e8887e3b58a8c92efb7.jpg)
Merck & Co. shares soared to a record high Wednesday, a day after the Food and Drug Administration approved the drug maker's treatment for a rare cardiovascular disease.
The FDA has approved Winrevair (sotatercept-csrk) for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1).
Data readout from Phase 3 clinical trial in the People's Republic of China evaluating F351 for the treatment of CHB-associated liver fibrosis expected by early 2025 U.S. Phase 2a clinical trial...
MM120 is a tartrate salt form of lyseride, a synthetic ergotamine, which acts as a partial agonist at human serotonin-2A (5-hydroxytryptamine-2A ) receptors.
RADNOR, Pa., March 26, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that it will release its fourth quarter and full year 2023...